nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—RET—autonomic nervous system—restless legs syndrome	0.0266	0.0353	CbGeAlD
Ruxolitinib—PRKG2—Circadian rythm related genes—BTBD9—restless legs syndrome	0.0233	0.0943	CbGpPWpGaD
Ruxolitinib—CAMK1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.0211	0.0854	CbGpPWpGaD
Ruxolitinib—DYRK1A—Circadian rythm related genes—BTBD9—restless legs syndrome	0.0199	0.0802	CbGpPWpGaD
Ruxolitinib—MAP3K2—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.0188	0.076	CbGpPWpGaD
Ruxolitinib—CAMK2G—nerve—restless legs syndrome	0.0176	0.0234	CbGeAlD
Ruxolitinib—MAP3K3—peripheral nervous system—restless legs syndrome	0.0175	0.0232	CbGeAlD
Ruxolitinib—LRRK2—nerve—restless legs syndrome	0.0174	0.0232	CbGeAlD
Ruxolitinib—RPS6KA6—brainstem—restless legs syndrome	0.0157	0.0209	CbGeAlD
Ruxolitinib—TAOK2—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.012	0.0486	CbGpPWpGaD
Ruxolitinib—ANKK1—nervous system—restless legs syndrome	0.0111	0.0148	CbGeAlD
Ruxolitinib—PHKG2—brainstem—restless legs syndrome	0.00979	0.013	CbGeAlD
Ruxolitinib—HIPK2—brainstem—restless legs syndrome	0.00942	0.0125	CbGeAlD
Ruxolitinib—PRKG2—nervous system—restless legs syndrome	0.0092	0.0122	CbGeAlD
Ruxolitinib—RPS6KA6—Insulin Signaling—MAP2K5—restless legs syndrome	0.00919	0.0371	CbGpPWpGaD
Ruxolitinib—LRRK2—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00912	0.0369	CbGpPWpGaD
Ruxolitinib—PRKG2—central nervous system—restless legs syndrome	0.00886	0.0118	CbGeAlD
Ruxolitinib—GRK1—nervous system—restless legs syndrome	0.00878	0.0117	CbGeAlD
Ruxolitinib—PRKCE—nervous system—restless legs syndrome	0.00859	0.0114	CbGeAlD
Ruxolitinib—DYRK1A—brainstem—restless legs syndrome	0.00847	0.0113	CbGeAlD
Ruxolitinib—GRK1—central nervous system—restless legs syndrome	0.00845	0.0112	CbGeAlD
Ruxolitinib—BMPR2—brainstem—restless legs syndrome	0.00844	0.0112	CbGeAlD
Ruxolitinib—PRKCE—central nervous system—restless legs syndrome	0.00827	0.011	CbGeAlD
Ruxolitinib—PLK1—nervous system—restless legs syndrome	0.00825	0.011	CbGeAlD
Ruxolitinib—RPS6KA6—nervous system—restless legs syndrome	0.00825	0.011	CbGeAlD
Ruxolitinib—MAST1—nervous system—restless legs syndrome	0.00825	0.011	CbGeAlD
Ruxolitinib—PLK1—central nervous system—restless legs syndrome	0.00794	0.0106	CbGeAlD
Ruxolitinib—RPS6KA6—central nervous system—restless legs syndrome	0.00794	0.0106	CbGeAlD
Ruxolitinib—MAST1—central nervous system—restless legs syndrome	0.00794	0.0106	CbGeAlD
Ruxolitinib—DCLK3—nervous system—restless legs syndrome	0.00782	0.0104	CbGeAlD
Ruxolitinib—CAMK1—spinal cord—restless legs syndrome	0.00765	0.0102	CbGeAlD
Ruxolitinib—MAP3K2—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.00763	0.0308	CbGpPWpGaD
Ruxolitinib—CAMK2G—brainstem—restless legs syndrome	0.00755	0.01	CbGeAlD
Ruxolitinib—DCLK3—central nervous system—restless legs syndrome	0.00753	0.01	CbGeAlD
Ruxolitinib—LRRK2—brainstem—restless legs syndrome	0.00748	0.00994	CbGeAlD
Ruxolitinib—PRKG2—brain—restless legs syndrome	0.00703	0.00935	CbGeAlD
Ruxolitinib—PLK3—nervous system—restless legs syndrome	0.00689	0.00915	CbGeAlD
Ruxolitinib—GRK1—brain—restless legs syndrome	0.00671	0.00892	CbGeAlD
Ruxolitinib—PLK3—central nervous system—restless legs syndrome	0.00663	0.00881	CbGeAlD
Ruxolitinib—PRKCE—brain—restless legs syndrome	0.00656	0.00872	CbGeAlD
Ruxolitinib—CAMK1—nervous system—restless legs syndrome	0.00644	0.00856	CbGeAlD
Ruxolitinib—MAP3K7—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.0064	0.0258	CbGpPWpGaD
Ruxolitinib—PLK1—brain—restless legs syndrome	0.00631	0.00838	CbGeAlD
Ruxolitinib—RPS6KA6—brain—restless legs syndrome	0.00631	0.00838	CbGeAlD
Ruxolitinib—MAST1—brain—restless legs syndrome	0.00631	0.00838	CbGeAlD
Ruxolitinib—JAK1—spinal cord—restless legs syndrome	0.00627	0.00833	CbGeAlD
Ruxolitinib—DCLK1—spinal cord—restless legs syndrome	0.00627	0.00833	CbGeAlD
Ruxolitinib—ROCK1—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.00626	0.0253	CbGpPWpGaD
Ruxolitinib—MARK2—nervous system—restless legs syndrome	0.00625	0.00831	CbGeAlD
Ruxolitinib—CAMK1—central nervous system—restless legs syndrome	0.0062	0.00824	CbGeAlD
Ruxolitinib—ROCK1—EPHB forward signaling—TF—restless legs syndrome	0.00618	0.0249	CbGpPWpGaD
Ruxolitinib—MARK2—central nervous system—restless legs syndrome	0.00602	0.008	CbGeAlD
Ruxolitinib—DAPK2—spinal cord—restless legs syndrome	0.00598	0.00795	CbGeAlD
Ruxolitinib—DCLK3—brain—restless legs syndrome	0.00598	0.00795	CbGeAlD
Ruxolitinib—MAP3K2—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.00593	0.0239	CbGpPWpGaD
Ruxolitinib—HIPK2—spinal cord—restless legs syndrome	0.00585	0.00778	CbGeAlD
Ruxolitinib—DAPK3—spinal cord—restless legs syndrome	0.00562	0.00748	CbGeAlD
Ruxolitinib—MAP3K2—Insulin Signaling—MAP2K5—restless legs syndrome	0.00545	0.022	CbGpPWpGaD
Ruxolitinib—ROCK1—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.00545	0.022	CbGpPWpGaD
Ruxolitinib—MAP3K2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00539	0.0218	CbGpPWpGaD
Ruxolitinib—TAOK3—brainstem—restless legs syndrome	0.00533	0.00709	CbGeAlD
Ruxolitinib—JAK3—nervous system—restless legs syndrome	0.00532	0.00707	CbGeAlD
Ruxolitinib—DCLK1—nervous system—restless legs syndrome	0.00528	0.00702	CbGeAlD
Ruxolitinib—JAK1—nervous system—restless legs syndrome	0.00528	0.00702	CbGeAlD
Ruxolitinib—PLK3—brain—restless legs syndrome	0.00526	0.007	CbGeAlD
Ruxolitinib—MAP3K2—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00524	0.0212	CbGpPWpGaD
Ruxolitinib—CAMK1D—nervous system—restless legs syndrome	0.00516	0.00685	CbGeAlD
Ruxolitinib—PHKG2—nervous system—restless legs syndrome	0.00513	0.00681	CbGeAlD
Ruxolitinib—JAK3—central nervous system—restless legs syndrome	0.00512	0.0068	CbGeAlD
Ruxolitinib—JAK1—central nervous system—restless legs syndrome	0.00509	0.00676	CbGeAlD
Ruxolitinib—DCLK1—central nervous system—restless legs syndrome	0.00509	0.00676	CbGeAlD
Ruxolitinib—LTK—brain—restless legs syndrome	0.00508	0.00676	CbGeAlD
Ruxolitinib—CAMK1D—central nervous system—restless legs syndrome	0.00497	0.0066	CbGeAlD
Ruxolitinib—STK16—nervous system—restless legs syndrome	0.00496	0.00659	CbGeAlD
Ruxolitinib—PHKG2—central nervous system—restless legs syndrome	0.00494	0.00656	CbGeAlD
Ruxolitinib—HIPK2—nervous system—restless legs syndrome	0.00493	0.00656	CbGeAlD
Ruxolitinib—CAMK1—brain—restless legs syndrome	0.00492	0.00654	CbGeAlD
Ruxolitinib—MAP3K19—nervous system—restless legs syndrome	0.00483	0.00642	CbGeAlD
Ruxolitinib—MARK2—brain—restless legs syndrome	0.00478	0.00635	CbGeAlD
Ruxolitinib—STK16—central nervous system—restless legs syndrome	0.00477	0.00635	CbGeAlD
Ruxolitinib—HIPK2—central nervous system—restless legs syndrome	0.00475	0.00631	CbGeAlD
Ruxolitinib—DAPK3—nervous system—restless legs syndrome	0.00474	0.0063	CbGeAlD
Ruxolitinib—CLK2—nervous system—restless legs syndrome	0.00469	0.00624	CbGeAlD
Ruxolitinib—CAMK2G—spinal cord—restless legs syndrome	0.00469	0.00624	CbGeAlD
Ruxolitinib—BMP2K—spinal cord—restless legs syndrome	0.00469	0.00624	CbGeAlD
Ruxolitinib—MAP3K3—Insulin Signaling—MAP2K5—restless legs syndrome	0.00469	0.0189	CbGpPWpGaD
Ruxolitinib—MAP3K19—central nervous system—restless legs syndrome	0.00465	0.00618	CbGeAlD
Ruxolitinib—LRRK2—spinal cord—restless legs syndrome	0.00465	0.00618	CbGeAlD
Ruxolitinib—MAP3K3—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00464	0.0187	CbGpPWpGaD
Ruxolitinib—DAPK3—central nervous system—restless legs syndrome	0.00456	0.00606	CbGeAlD
Ruxolitinib—ROCK1—nervous system—restless legs syndrome	0.00455	0.00605	CbGeAlD
Ruxolitinib—CLK2—central nervous system—restless legs syndrome	0.00452	0.00601	CbGeAlD
Ruxolitinib—DYRK1A—nervous system—restless legs syndrome	0.00444	0.0059	CbGeAlD
Ruxolitinib—TAOK2—brain—restless legs syndrome	0.00442	0.00588	CbGeAlD
Ruxolitinib—BMPR2—nervous system—restless legs syndrome	0.00442	0.00587	CbGeAlD
Ruxolitinib—ROCK1—central nervous system—restless legs syndrome	0.00438	0.00582	CbGeAlD
Ruxolitinib—PRKCE—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00428	0.0173	CbGpPWpGaD
Ruxolitinib—DYRK1A—central nervous system—restless legs syndrome	0.00427	0.00568	CbGeAlD
Ruxolitinib—BMPR2—central nervous system—restless legs syndrome	0.00426	0.00566	CbGeAlD
Ruxolitinib—MAP3K7—spinal cord—restless legs syndrome	0.00422	0.00561	CbGeAlD
Ruxolitinib—TYK2—spinal cord—restless legs syndrome	0.00415	0.00551	CbGeAlD
Ruxolitinib—MKNK2—spinal cord—restless legs syndrome	0.00409	0.00544	CbGeAlD
Ruxolitinib—JAK3—brain—restless legs syndrome	0.00406	0.0054	CbGeAlD
Ruxolitinib—JAK1—brain—restless legs syndrome	0.00404	0.00537	CbGeAlD
Ruxolitinib—DCLK1—brain—restless legs syndrome	0.00404	0.00537	CbGeAlD
Ruxolitinib—PLK4—brain—restless legs syndrome	0.00401	0.00533	CbGeAlD
Ruxolitinib—RET—spinal cord—restless legs syndrome	0.00399	0.0053	CbGeAlD
Ruxolitinib—CAMK2G—nervous system—restless legs syndrome	0.00396	0.00526	CbGeAlD
Ruxolitinib—BMP2K—nervous system—restless legs syndrome	0.00396	0.00526	CbGeAlD
Ruxolitinib—CAMK1D—brain—restless legs syndrome	0.00394	0.00524	CbGeAlD
Ruxolitinib—LRRK2—nervous system—restless legs syndrome	0.00392	0.00521	CbGeAlD
Ruxolitinib—PHKG2—brain—restless legs syndrome	0.00392	0.00521	CbGeAlD
Ruxolitinib—DAPK2—brain—restless legs syndrome	0.00385	0.00512	CbGeAlD
Ruxolitinib—CAMK2G—central nervous system—restless legs syndrome	0.00381	0.00506	CbGeAlD
Ruxolitinib—BMP2K—central nervous system—restless legs syndrome	0.00381	0.00506	CbGeAlD
Ruxolitinib—STK16—brain—restless legs syndrome	0.00379	0.00504	CbGeAlD
Ruxolitinib—LRRK2—central nervous system—restless legs syndrome	0.00377	0.00502	CbGeAlD
Ruxolitinib—JAK2—spinal cord—restless legs syndrome	0.00377	0.00501	CbGeAlD
Ruxolitinib—HIPK2—brain—restless legs syndrome	0.00377	0.00501	CbGeAlD
Ruxolitinib—JAK1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00376	0.0152	CbGpPWpGaD
Ruxolitinib—ROCK1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.0037	0.015	CbGpPWpGaD
Ruxolitinib—MAP3K19—brain—restless legs syndrome	0.00369	0.00491	CbGeAlD
Ruxolitinib—MAP3K3—spinal cord—restless legs syndrome	0.00364	0.00483	CbGeAlD
Ruxolitinib—DAPK3—brain—restless legs syndrome	0.00362	0.00481	CbGeAlD
Ruxolitinib—MAP3K2—nervous system—restless legs syndrome	0.00359	0.00477	CbGeAlD
Ruxolitinib—CLK2—brain—restless legs syndrome	0.00359	0.00477	CbGeAlD
Ruxolitinib—RET—SIDS Susceptibility Pathways—TF—restless legs syndrome	0.00358	0.0145	CbGpPWpGaD
Ruxolitinib—TYK2—nervous system—restless legs syndrome	0.00349	0.00464	CbGeAlD
Ruxolitinib—ROCK1—brain—restless legs syndrome	0.00348	0.00462	CbGeAlD
Ruxolitinib—MAP3K2—central nervous system—restless legs syndrome	0.00346	0.0046	CbGeAlD
Ruxolitinib—MKNK2—nervous system—restless legs syndrome	0.00345	0.00458	CbGeAlD
Ruxolitinib—DYRK1A—brain—restless legs syndrome	0.00339	0.00451	CbGeAlD
Ruxolitinib—BMPR2—brain—restless legs syndrome	0.00338	0.00449	CbGeAlD
Ruxolitinib—TYK2—central nervous system—restless legs syndrome	0.00336	0.00447	CbGeAlD
Ruxolitinib—RET—nervous system—restless legs syndrome	0.00336	0.00447	CbGeAlD
Ruxolitinib—MKNK2—central nervous system—restless legs syndrome	0.00332	0.00441	CbGeAlD
Ruxolitinib—TAOK3—spinal cord—restless legs syndrome	0.00331	0.00441	CbGeAlD
Ruxolitinib—PRKCE—Signaling by NGF—MAP2K5—restless legs syndrome	0.00329	0.0133	CbGpPWpGaD
Ruxolitinib—ROCK1—Focal Adhesion—MAP2K5—restless legs syndrome	0.00326	0.0132	CbGpPWpGaD
Ruxolitinib—RET—central nervous system—restless legs syndrome	0.00324	0.0043	CbGeAlD
Ruxolitinib—NUAK2—brain—restless legs syndrome	0.00323	0.00429	CbGeAlD
Ruxolitinib—JAK2—nervous system—restless legs syndrome	0.00318	0.00422	CbGeAlD
Ruxolitinib—JAK1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00311	0.0125	CbGpPWpGaD
Ruxolitinib—MAP3K3—nervous system—restless legs syndrome	0.00306	0.00407	CbGeAlD
Ruxolitinib—JAK2—central nervous system—restless legs syndrome	0.00306	0.00407	CbGeAlD
Ruxolitinib—BMP2K—brain—restless legs syndrome	0.00302	0.00402	CbGeAlD
Ruxolitinib—CAMK2G—brain—restless legs syndrome	0.00302	0.00402	CbGeAlD
Ruxolitinib—LRRK2—brain—restless legs syndrome	0.003	0.00398	CbGeAlD
Ruxolitinib—MAP3K3—central nervous system—restless legs syndrome	0.00295	0.00392	CbGeAlD
Ruxolitinib—TAOK3—nervous system—restless legs syndrome	0.00279	0.00371	CbGeAlD
Ruxolitinib—MAP3K2—brain—restless legs syndrome	0.00275	0.00365	CbGeAlD
Ruxolitinib—MAP3K7—Insulin Signaling—MAP2K5—restless legs syndrome	0.00272	0.011	CbGpPWpGaD
Ruxolitinib—MAP3K7—brain—restless legs syndrome	0.00272	0.00361	CbGeAlD
Ruxolitinib—TAOK3—central nervous system—restless legs syndrome	0.00269	0.00357	CbGeAlD
Ruxolitinib—TYK2—brain—restless legs syndrome	0.00267	0.00355	CbGeAlD
Ruxolitinib—IRAK1—brain—restless legs syndrome	0.00264	0.0035	CbGeAlD
Ruxolitinib—MKNK2—brain—restless legs syndrome	0.00264	0.0035	CbGeAlD
Ruxolitinib—MAP3K7—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00262	0.0106	CbGpPWpGaD
Ruxolitinib—RET—brain—restless legs syndrome	0.00257	0.00342	CbGeAlD
Ruxolitinib—JAK2—brain—restless legs syndrome	0.00243	0.00323	CbGeAlD
Ruxolitinib—JAK1—Signaling by NGF—MAP2K5—restless legs syndrome	0.00239	0.00965	CbGpPWpGaD
Ruxolitinib—MAP3K3—brain—restless legs syndrome	0.00234	0.00311	CbGeAlD
Ruxolitinib—JAK2—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.00231	0.00935	CbGpPWpGaD
Ruxolitinib—TYK2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00229	0.00926	CbGpPWpGaD
Ruxolitinib—PRKCE—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.00216	0.00872	CbGpPWpGaD
Ruxolitinib—TAOK3—brain—restless legs syndrome	0.00214	0.00284	CbGeAlD
Ruxolitinib—JAK2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00211	0.00851	CbGpPWpGaD
Ruxolitinib—PRKG2—Hemostasis—TF—restless legs syndrome	0.00202	0.00814	CbGpPWpGaD
Ruxolitinib—JAK3—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.00182	0.00736	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—MAP2K5—restless legs syndrome	0.00182	0.00734	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—MAP2K5—restless legs syndrome	0.00176	0.00712	CbGpPWpGaD
Ruxolitinib—JAK2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00174	0.00702	CbGpPWpGaD
Ruxolitinib—JAK1—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.00157	0.00633	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—MAP2K5—restless legs syndrome	0.00134	0.0054	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—MAP2K5—restless legs syndrome	0.00128	0.00517	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—MAP2K5—restless legs syndrome	0.0012	0.00486	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—TF—restless legs syndrome	0.00111	0.0045	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—MAP2K5—restless legs syndrome	0.00109	0.0044	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—TF—restless legs syndrome	0.000939	0.00379	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000877	0.00354	CbGpPWpGaD
Ruxolitinib—CYP3A4—nervous system—restless legs syndrome	0.000849	0.00113	CbGeAlD
Ruxolitinib—CYP3A4—central nervous system—restless legs syndrome	0.000817	0.00109	CbGeAlD
Ruxolitinib—JAK1—Hemostasis—TF—restless legs syndrome	0.000808	0.00326	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MAP2K5—restless legs syndrome	0.000707	0.00285	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MAP2K5—restless legs syndrome	0.000596	0.00241	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MAP2K5—restless legs syndrome	0.000513	0.00207	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MAP2K5—restless legs syndrome	0.000505	0.00204	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TF—restless legs syndrome	0.000452	0.00183	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MAP2K5—restless legs syndrome	0.00039	0.00158	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MAP2K5—restless legs syndrome	0.000379	0.00153	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—POMC—restless legs syndrome	0.000377	0.00152	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MAP2K5—restless legs syndrome	0.000367	0.00148	CbGpPWpGaD
Ruxolitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000324	0.00131	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—POMC—restless legs syndrome	0.000324	0.00131	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—POMC—restless legs syndrome	0.00032	0.00129	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—POMC—restless legs syndrome	0.000315	0.00127	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—POMC—restless legs syndrome	0.000296	0.0012	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—POMC—restless legs syndrome	0.000294	0.00119	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MAP2K5—restless legs syndrome	0.000287	0.00116	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—POMC—restless legs syndrome	0.000273	0.0011	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—POMC—restless legs syndrome	0.000268	0.00108	CbGpPWpGaD
Ruxolitinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000263	0.00106	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—POMC—restless legs syndrome	0.000248	0.001	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—POMC—restless legs syndrome	0.000235	0.00095	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—POMC—restless legs syndrome	0.000231	0.000935	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—POMC—restless legs syndrome	0.000214	0.000863	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—POMC—restless legs syndrome	0.00021	0.000849	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—POMC—restless legs syndrome	0.000174	0.000702	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—POMC—restless legs syndrome	0.000158	0.000637	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—POMC—restless legs syndrome	0.000147	0.000593	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—POMC—restless legs syndrome	0.00014	0.000564	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—POMC—restless legs syndrome	0.000132	0.000532	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—POMC—restless legs syndrome	0.000126	0.00051	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—POMC—restless legs syndrome	0.000124	0.000501	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—POMC—restless legs syndrome	0.00012	0.000483	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—POMC—restless legs syndrome	9.6e-05	0.000388	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—POMC—restless legs syndrome	9.32e-05	0.000376	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—POMC—restless legs syndrome	9.04e-05	0.000365	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—POMC—restless legs syndrome	7.06e-05	0.000285	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—POMC—restless legs syndrome	2.39e-05	9.64e-05	CbGpPWpGaD
